Fundraising FoxImpriMed
9 known investors
Find your way into ImpriMed
Sign up to see every warm intro you have to ImpriMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImpriMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
Founders & leadership
Investors · 9
How we know: Blue Bear Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Han River Partners's portfolio page · Not right? Tell us
How we know: pear.vc · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: plugandplaytechcenter.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through ImpriMed went on to found or lead other companies.
In the news
Frequently asked questions
- What does ImpriMed do?
- ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
- Who are ImpriMed's investors?
- ImpriMed's investors include Blue Bear Ventures, DFJ DragonFund, Draper Associates, Han River Partners, Pear VC, Plug and Play Ventures, Sazze, Sk Telecom Venture Capital, Llc and 1 more.